AC Immune SA

ACIUNASDAQ · USD
2.11USD+0.02 (+0.96%)
155

AC Immune SA (ACIU) Option Chain

Read more

Tracking the ACIU option chain helps you see every strike and expiry on AC Immune SA in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ACIU options activity at a glance. Use our scanner to monitor the ACIU option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ACIU stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ACIU options are being actively traded, and where they are not.

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD).

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
74.9159500.200.00—0.202.50+17.370.102.300.390.81049025.09
99.831,32600.250.00—0.255.00+134.741.004.802.890.01000.17
100.006401.900.00—1.907.50+252.113.507.305.390.01000.00

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank70.24% High
  • Market cap (M$)213
  • 52 weeks high-46.41%
  • 52 weeks low3.47%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$8.58
    306.64% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-04
  • P/E—
  • Future P/E6.45
  • EPS (ttm)-0.52
  • EPS growth next 5 years—

As of Nov 16, 2026